Schonfeld Strategic Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-59,107	Closed	-$521K	–	2727
2025 Q4	$521K	Buy	+59,107	New	+$325K	﹤0.01%	1379
2025 Q2	–	Sell	-379,001	Closed	-$1.74M	–	2585
2025 Q1	$1.74M	Buy	379,001 +108,460	+40%	+$506K	0.01%	1021
2024 Q4	$1.3M	Buy	+270,541	New	+$1.3M	0.01%	1012
2023 Q4	–	Sell	-22,241	Closed	-$96.1K	–	2265
2023 Q3	$96.1K	Buy	+22,241	New	+$124K	﹤0.01%	1499
2022 Q4	–	Sell	-49,991	Closed	-$494K	–	3048
2022 Q3	$494K	Buy	+49,991	New	+$528K	﹤0.01%	1762
2021 Q4	–	Sell	-10,000	Closed	-$172K	–	2596
2021 Q3	$172K	Buy	+10,000	New	+$175K	﹤0.01%	1812
2020 Q1	–	Sell	-14,284	Closed	-$235K	–	1554
2019 Q4	$235K	Buy	+14,284	New	+$216K	0.01%	1095
2016 Q4	–	Sell	-43,169	Closed	-$719K	–	658
2016 Q3	$719K	Buy	+43,169	New	+$581K	0.12%	227